Gaucher Disease

Update on diagnosing and therapy monitoring

  1. Home
  2. Science
  3. Gaucher Disease – Update on diagnosing and therapy monitoring

Knowing Gaucher Disease (GD), the most common lysosomal storage disorder, is crucial when being faced with unspecific abnormalities in many organs like brain, liver, spleen and bones.

Our speaker Prof. Peter Bauer, MD will host the webinar “Gaucher Disease: beyond the paradigms based on scientific knowledge”. He will discuss physiopathology, clinical symptoms as well as deep-dive into the diagnostic methods for this rare genetic disorder.  

The webinar will also provide an overview of Lyso-Gb1 – a robust biomarker for monitoring response to therapy for patients with GD. Prof. Bauer will introduce and walk you through myLSDapp an easy to use mobile app to monitor and manage treatment for GD patients.

Webinar content:

  • Physiopathology
  • Clinical signs & Symptoms
  • Diagnostics & Treatment
  • Lyso-Gb1 biomarker
  • myLSDapp

Our Speaker

Dr. Peter Bauer Chief Scientific Officer

Dr. Peter Bauer, MD serves as CENTOGENE’s Chief Scientific Officer, where he combines clinical and medical understanding in genetic testing with an excellent knowledge of the latest scientific development, based on his extraordinary experience especially in high-throughput genetic testing using next-generation sequencing.

Dr. Bauer received his board certification in Human Genetics in 2006 and headed the molecular diagnostic laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Moreover, he is Vice President of the German Society of Neurogenetics (DGNG). Peter has authored more than 140 publications in neurogenetics, oncogenetics, cardiogenetics and sequencing technology.